NABL, CAP, ISO
Overview of HIV 1 And 2 Antibody - Chromatography
What is HIV 1 And 2 Antibody - Chromatography?
Get this test done one to three months after you think you may have been exposed to the virus (the average time for the antibody to be detected is two to eight weeks after exposure to the virus); once a year if you are at increased risk of being exposed to the virus; when your doctor thinks that your signs and symptoms may be due to HIV; before becoming pregnant or when you are pregnant.
Why is HIV 1 And 2 Antibody - Chromatography done?
- To screen for and diagnose HIV infection
- If you are pregnant or planning to get pregnant
- If you are diagnosed with Hepatitis B, C, Tubercolosis or any other sexually transmitted disease
- Annual screening is advised for those who are at high risk for HIV infection like having a HIV positive sex partner, moltiple sexual partners, homosexual people, sharing needles
Preparation for HIV 1 And 2 Antibody - Chromatography
- No special preparation required
Sample Type for HIV 1 And 2 Antibody - Chromatography
The sample type collected for HIV 1 And 2 Antibody - Chromatography is: Blood
Interpreting HIV 1 And 2 Antibody - Chromatography results
- A negative HIV antibody test usually indicates that a person does not have HIV infection. A negative test only means that their is no evidence of disease at the time of the test. The HIV antibody tests does not detect an HIV infection soon after exposure, before the development of antibodies. Most people produce detectable levels of antibody 3 to 12 weeks after exposure. If someone is screened with an HIV antibody test too soon, the result may be negative despite the fact that the person is infected. For those who are at increased risk of HIV infection, it is important to get this screening test done frequently to check for possible exposure to the virus
- If someone tests positive on both the initial screening and supplemental testing, then that person is considered to be infected with HIV
We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic healthcare services and efficient service. With over 3368 diagnostic and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. Our key competitive strengths are: Business model focused on the patient as a customer and an established consumer healthcare brand associated with quality services, in a market where patients generally choose their diagnostic healthcare service provider. Well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry. A network whose growth yields greater economies of scale, combined with a hub and spoke model that is scalable for further growth. Centralized information technology platform that fully integrates our network and is scalable. Attractive financial performance, financial profile and return on invested capital. Experienced leadership team with strong industry expertise and successful track record. Some of our laboratories have achieved International Organization for Standardization, or ISO, certification for their quality systems. Our National Reference Laboratory has obtained ISO 9001:2008 certification (for the performance of routine and advanced diagnostic pathology testing services, including clinical trials), ISO 15189:2007 (for quality management in medical laboratories), ISO 15189:2012 certification (in the field of medical testing) and ISO 27001:2013 certification (for establishing an effective information management system that maintains and processes information security at our data center).